Table 1. The correlation of KIF3C expression with the prostate cancer clinical features.
Variable | Group | KIF3C protein expression | P value | ||
n | High | Low | |||
Age | <70 | 45 | 28 | 17 | 0.474 |
≥70 | 35 | 19 | 16 | ||
Lymph node metastasis | Positive | 17 | 14 | 3 | 0.026 |
Negative | 63 | 33 | 30 | ||
Surgical margin status | Positive | 14 | 10 | 4 | 0.289 |
Negative | 66 | 37 | 29 | ||
Seminal vesicle invasion | Positive | 26 | 20 | 6 | 0.022 |
Negative | 54 | 27 | 27 | ||
PCa stage | T1 | 53 | 29 | 26 | 0.105 |
T2/T3 | 27 | 18 | 7 | ||
Preoperative PSA | <4 | 2 | 1 | 1 | 0.038 |
4-10 | 33 | 14 | 19 | ||
>10 | 45 | 32 | 13 | ||
Gleason score | <7 | 31 | 15 | 16 | 0.035 |
7 | 27 | 14 | 13 | ||
>7 | 22 | 18 | 4 | ||
Angiolymphatic invasion | Positive | 20 | 15 | 5 | 0.6576 |
Negative | 60 | 32 | 28 | ||
Biochemical recurrence | Absence | 59 | 34 | 25 | 0.7324 |
Presence | 21 | 13 | 8 |